Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synergy Pharma (SGYP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 431,655
  • Shares Outstanding, K 246,660
  • Annual Sales, $ 16,820 K
  • Annual Income, $ -224,340 K
  • 36-Month Beta 1.17
  • Price/Sales 26.10
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.72 +1.74%
on 03/28/18
2.03 -13.79%
on 03/21/18
-0.18 (-9.33%)
since 03/20/18
3-Month
1.72 +1.74%
on 03/28/18
2.80 -37.50%
on 01/25/18
-0.65 (-27.08%)
since 01/19/18
52-Week
1.68 +4.17%
on 11/15/17
4.84 -63.84%
on 06/26/17
-2.36 (-57.42%)
since 04/20/17

Most Recent Stories

More News
Options Traders Expect Huge Moves in Synergy Pharmaceuticals (SGYP) Stock

Investors in Synergy Pharmaceuticals (SGYP) need to pay close attention to the stock based on moves in the options market lately.

SGYP : 1.75 (-1.69%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Reminds Investors With Losses In Excess of $50,000 to Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / April 10, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals Inc. ("Synergy" or "the Company")...

SGYP : 1.75 (-1.69%)
Glancy Prongay & Murray LLP Reminds Investors of the April 10, 2018 Deadline in the Class Action Lawsuit Against Synergy Pharmaceuticals Inc. (SGYP)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the April 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased...

SGYP : 1.75 (-1.69%)
SGYP DEADLINE TODAY: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018

NEW YORK, NY / ACCESSWIRE / April 10, 2018 / The Law Offices of Vincent Wong announce that class action lawsuits have been commenced in the United States District Court for the Eastern District of New...

SGYP : 1.75 (-1.69%)
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Synergy Pharmaceuticals Inc. ("Synergy" or the "Company") (NASDAQ:SGYP) and...

SGYP : 1.75 (-1.69%)
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Synergy Pharmaceuticals Inc. Investors (SGYP)

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired Synergy Pharmaceuticals Inc. ("Synergy"...

SGYP : 1.75 (-1.69%)
EQUITY NOTICE: Rosen Law Firm Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Deadline in Class Action - SGYP

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) from September 5, 2017 through November 14, 2017, inclusive...

SGYP : 1.75 (-1.69%)
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / April 9, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals Inc. ("Synergy" or "the Company")...

SGYP : 1.75 (-1.69%)
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Before April 10th

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf...

SGYP : 1.75 (-1.69%)
DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / The following statement is being issued by Levi & Korsinsky, LLP:

SGYP : 1.75 (-1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant-...

See More

Key Turning Points

2nd Resistance Point 1.81
1st Resistance Point 1.78
Last Price 1.75
1st Support Level 1.73
2nd Support Level 1.71

See More

52-Week High 4.84
Fibonacci 61.8% 3.63
Fibonacci 50% 3.26
Fibonacci 38.2% 2.89
Last Price 1.75
52-Week Low 1.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar